Working with transmissible spongiform encephalopathy agents

ILAR Journal

Volumn 46, Issue 1, 2005, Pages 44-52

  Brown, Paul ^a   Abee, Christian R ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Prion disease; Transmissible spongiform encephalopathy

Indexed keywords

AMYLOID PROTEIN; PRION PROTEIN;

AGRICULTURE; ALZHEIMER DISEASE; BIOLOGICAL WARFARE; BIOSAFETY; CREUTZFELDT JAKOB DISEASE; DISINFECTION; ENVIRONMENTAL PROTECTION; EXPERIMENTAL ANIMAL WELFARE; GOOD LABORATORY PRACTICE; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HIGH TEMPERATURE PROCEDURES; HUMAN; LABORATORY PERSONNEL; MICROWAVE RADIATION; NONHUMAN; OCCUPATIONAL SAFETY; PARKINSON DISEASE; PATHOGENESIS; PRION DISEASE; PROTEIN FOLDING; REVIEW; ULTRAVIOLET RADIATION; UNITED STATES; ANIMAL; DANGEROUS GOODS; DISEASE TRANSMISSION; HAZARDOUS WASTE; METHODOLOGY; PRION; SOCIAL CONTROL;

ANIMALIA; BOVINAE;

ANIMALS; CONTAINMENT OF BIOHAZARDS; HAZARDOUS SUBSTANCES; HUMANS; PRION DISEASES; PRIONS; SOCIAL CONTROL, FORMAL;

EID: 14744273321     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.46.1.44     Document Type: Review

References (14)

1. Brown P, Bradley R. 1998. 1755 and all that: A historical primer of transmissible sppongiform encephalopathy, Br Med J 317:1688-1692.
2. Brown P. Gajdusek DC. 1991. Survival of scrapie virus after 3 years' interment. Lancet 337:269-270.
3. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. 2001. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: Background, evolution, and current concerns. Emerg Inf Dis 7:6-16.
4. Bruce M, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousins S, Fraser H, Bostock CJ. 1997. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389:498-501.
5. Caughey B, Gregory RJ, Callahan MA, Wong C, Baron GS, Xiong L-W. 2001. Interactions and conversions of prion protein isoforms. Adv Protein Chem 57:139-169.
6. Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, Lasmézas CI, Deslys J-P. 2004. Novel methods for disinfection of prion-contaminated medical devices. Lancet 364: 521-526.
7. Miller MW, Williams ES, Hobbs NT, Wolfe LL. 2004. Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10:1003-1006.
8. PL [Public Law] 107-188. 2002. Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Washington DC: GPO. June 12, 2002.
9. Prusiner SB. 2001. Shattuck lecture - Neurodegenerative diseases and prions. N Engl J Med 344:1516-1526.
10. Richmond JY, McKinney R, eds. 1999. Biosafety in Microbiological and Biomedical Laboratories. 4th ed. Washington DC: GPO.
11. Taylor DM. 2000. Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J 159:10-17.
12. USDA/APHIS [US Department of Agriculture/Animal and Plant Health Inspection Service]. 1999. Agricultural Bioterrorism Protection Act of 2002: Possession, Use, and Transfer of Biological Agents and Toxins, Interim Final Rule. Washington DC: GPO.
13. WHO [World Health Organization]. 1999. Infection Control Guidelines for Transmissible Spongiform Encepbalopathies. Report of a WHO Consultation WHO/CDS/CSR/APH/2000.3. Geneva: WHO, March 23, 1999.
14. WHO [World Health Organization]. 2003. Guidelines on Transmissible Spongiform Encephalopathies in Relation to Biological and Pharmaceutical Products, ECBS. Available online (http://www.who.int/biologicals - Meeting Reports, TSEs).